chr18-3457778-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003244.4(TGIF1):c.657T>G(p.Thr219Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0147 in 1,613,990 control chromosomes in the GnomAD database, including 1,204 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.052 ( 562 hom., cov: 32)
Exomes 𝑓: 0.011 ( 642 hom. )
Consequence
TGIF1
NM_003244.4 synonymous
NM_003244.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -5.48
Publications
9 publications found
Genes affected
TGIF1 (HGNC:11776): (TGFB induced factor homeobox 1) The protein encoded by this gene is a member of the three-amino acid loop extension (TALE) superclass of atypical homeodomains. TALE homeobox proteins are highly conserved transcription regulators. This particular homeodomain binds to a previously characterized retinoid X receptor responsive element from the cellular retinol-binding protein II promoter. In addition to its role in inhibiting 9-cis-retinoic acid-dependent RXR alpha transcription activation of the retinoic acid responsive element, the protein is an active transcriptional co-repressor of SMAD2 and may participate in the transmission of nuclear signals during development and in the adult. Mutations in this gene are associated with holoprosencephaly type 4, which is a structural anomaly of the brain. Alternative splicing has been observed at this locus and multiple splice variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2013]
TGIF1 Gene-Disease associations (from GenCC):
- holoprosencephaly 4Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.05).
BP6
Variant 18-3457778-T-G is Benign according to our data. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-3457778-T-G is described in CliVar as Benign/Likely_benign. Clinvar id is 259019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.48 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0522 AC: 7939AN: 152090Hom.: 556 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
7939
AN:
152090
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0190 AC: 4764AN: 251380 AF XY: 0.0156 show subpopulations
GnomAD2 exomes
AF:
AC:
4764
AN:
251380
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0108 AC: 15737AN: 1461782Hom.: 642 Cov.: 31 AF XY: 0.0102 AC XY: 7389AN XY: 727212 show subpopulations
GnomAD4 exome
AF:
AC:
15737
AN:
1461782
Hom.:
Cov.:
31
AF XY:
AC XY:
7389
AN XY:
727212
show subpopulations
African (AFR)
AF:
AC:
5835
AN:
33480
American (AMR)
AF:
AC:
856
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
542
AN:
26136
East Asian (EAS)
AF:
AC:
19
AN:
39700
South Asian (SAS)
AF:
AC:
381
AN:
86258
European-Finnish (FIN)
AF:
AC:
442
AN:
53312
Middle Eastern (MID)
AF:
AC:
216
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
6107
AN:
1112008
Other (OTH)
AF:
AC:
1339
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1039
2078
3117
4156
5195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0523 AC: 7967AN: 152208Hom.: 562 Cov.: 32 AF XY: 0.0507 AC XY: 3773AN XY: 74432 show subpopulations
GnomAD4 genome
AF:
AC:
7967
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
3773
AN XY:
74432
show subpopulations
African (AFR)
AF:
AC:
6787
AN:
41484
American (AMR)
AF:
AC:
427
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
68
AN:
3472
East Asian (EAS)
AF:
AC:
6
AN:
5186
South Asian (SAS)
AF:
AC:
18
AN:
4828
European-Finnish (FIN)
AF:
AC:
78
AN:
10618
Middle Eastern (MID)
AF:
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
AC:
436
AN:
68012
Other (OTH)
AF:
AC:
113
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
342
685
1027
1370
1712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
71
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Holoprosencephaly 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Holoprosencephaly sequence Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.